It has been established that under hypoxic situations, melanoma cells release the high-mobility group box 1 (HMGB1) protein, which promotes the M2 macrophage accumulation and IL-10 production in the tumor microenvironment [117], activating advanced glycation end-product receptors and leading to an inflammatory response. The gene discussed is HMGB1; the disease is neoplasm.